787
Participants
Start Date
June 30, 2014
Primary Completion Date
September 30, 2015
Study Completion Date
September 30, 2015
FS MDPI
"FS MDPI is an inhalation-driven multidose dry powder inhaler (MDPI) containing fluticasone propionate (Fp) and salmeterol xinafoate (Sx) dispersed in a lactose monohydrate excipient and contained within a reservoir. A metered dose of drug is delivered to a dose cup via an air pulse activated when the cap is opened.~During the treatment period, participants were randomized to either 100/12.5 mcg Fp/Sx or 50/12.5 mcg Fp/Sx in the morning and evening for a total daily dose of 200/25 mcg or 100/25 mcg Fp/Sx.~Participants were instructed to rinse their mouth and expectorate (not swallow) after study drug administration."
Fp MDPI
"Fp MDPI is an inhalation-driven multidose dry powder inhaler (MDPI) containing fluticasone propionate dispersed in a lactose monohydrate excipient and contained within a reservoir. A metered dose of drug is delivered to a dose cup via an air pulse activated when the cap is opened.~During the treatment period, participants were randomized to either 100 mcg or 50 mcg of Fp one inhalation twice a day for a total daily dose of 200 mcg or 100 mcg.~Participants were instructed to rinse their mouth and expectorate (not swallow) after study drug administration."
Placebo MDPI
Placebo administered via a multidose dry powder inhaler (MDPI) one puff in the morning and one puff in the evening for 12 weeks.
albuterol/salbutamol
A short-acting β2-adrenergic agonists (SABA), albuterol/salbutamol hydrofluoroalkane (HFA) metered dose inhaler (MDI), was provided to be used as needed for the relief of asthma symptoms during both the run-in and treatment periods (to replace the subject's current rescue medication).
Beclomethasone dipropionate
QVAR (beclomethasone dipropionate) 40 mcg inhalation aerosol is a pressurized MDI that contains a Food and Drug Administration (FDA)-approved formulation of beclomethasone dipropionate. Patients took 1 puff twice a day from open-label QVAR 40 mcg hydrofluoroalkane (specifically, HFA-134a) metered-dose inhaler (MDI) for the duration of the Run-in Period (14-21 days) and prior to randomization. A clinically equivalent dose of inhaled corticosteroid (ICS) was substituted in countries where QVAR 40 mcg was not available.
Teva Investigational Site 12397, Birmingham
Teva Investigational Site 12375, Glendale
Teva Investigational Site 12395, Cypress
Teva Investigational Site 12476, Encinitas
Teva Investigational Site 12586, Fountain Valley
Teva Investigational Site 12591, Fresno
Teva Investigational Site 12372, Huntington Beach
Teva Investigational Site 12365, Los Angeles
Teva Investigational Site 12381, Los Angeles
Teva Investigational Site 12401, Los Angeles
Teva Investigational Site 12394, Mission Viejo
Teva Investigational Site 12490, Rancho Mirage
Teva Investigational Site 12393, Riverside
Teva Investigational Site 12366, Rolling Hills Estates
Teva Investigational Site 12383, San Diego
Teva Investigational Site 12370, San Jose
Teva Investigational Site 12371, Stockton
Teva Investigational Site 12579, Upland
Teva Investigational Site 12379, Centennial
Teva Investigational Site 12386, Centennial
Teva Investigational Site 12596, Colorado Springs
Teva Investigational Site 12584, Longmont
Teva Investigational Site 12484, Waterbury
Teva Investigational Site 12590, Waterbury
Teva Investigational Site 12493, Clearwater
Teva Investigational Site 12992, Largo
Teva Investigational Site 12376, Miami
Teva Investigational Site 12390, Miami
Teva Investigational Site 12583, Orlando
Teva Investigational Site 12481, Tallahassee
Teva Investigational Site 12491, Winter Park
Teva Investigational Site 12997, Decatur
Teva Investigational Site 12392, Savannah
Teva Investigational Site 12592, Shiloh
Teva Investigational Site 12483, Lenexa
Teva Investigational Site 12399, Baltimore
Teva Investigational Site 12391, Bethesda
Teva Investigational Site 12589, Columbia
Teva Investigational Site 12369, Rockville
Teva Investigational Site 12396, Fall River
Teva Investigational Site 12384, North Dartmouth
Teva Investigational Site 12585, North Dartmouth
Teva Investigational Site 12588, Ypsilanti
Teva Investigational Site 12494, St Louis
Teva Investigational Site 12595, St Louis
Teva Investigational Site 12594, Missoula
Teva Investigational Site 12385, Ocean City
Teva Investigational Site 12380, Skillman
Teva Investigational Site 12587, Brooklyn
Teva Investigational Site 12485, Rockville Centre
Teva Investigational Site 12475, Huntersville
Teva Investigational Site 12364, Raleigh
Teva Investigational Site 12374, Canton
Teva Investigational Site 12480, Cincinnati
Teva Investigational Site 12492, Cincinnati
Teva Investigational Site 12487, Middleburg Heights
Teva Investigational Site 12488, Sylvania
Teva Investigational Site 12377, Edmond
Teva Investigational Site 12368, Medford
Teva Investigational Site 12382, Portland
Teva Investigational Site 12400, Pittsburgh
Teva Investigational Site 12473, Upland
Teva Investigational Site 12389, Greenville
Teva Investigational Site 12580, Mt. Pleasant
Teva Investigational Site 12398, Orangeburg
Teva Investigational Site 12991, Knoxville
Teva Investigational Site 12990, Cypress
Teva Investigational Site 12373, Dallas
Teva Investigational Site 12402, El Paso
Teva Investigational Site 12582, New Braunfels
Teva Investigational Site 12363, San Antonio
Teva Investigational Site 12482, San Antonio
Teva Investigational Site 12477, Waco
Teva Investigational Site 12478, Murray
Teva Investigational Site 12388, South Burlington
Teva Investigational Site 12378, Milwaukee
Teva Investigational Site 11065, Toronto
Teva Investigational Site 11067, Montreal
Teva Investigational Site 11068, Vancouver
Teva Investigational Site 54084, Neratovice
Teva Investigational Site 54088, Prague
Teva Investigational Site 54087, Rokycany
Teva Investigational Site 51134, Budapest
Teva Investigational Site 51143, Budapest
Teva Investigational Site 51144, Budapest
Teva Investigational Site 51140, Debrecen
Teva Investigational Site 51142, Deszk
Teva Investigational Site 51165, Dombóvár
Teva Investigational Site 51145, Kiskunhalas
Teva Investigational Site 51141, Miskolc
Teva Investigational Site 51133, Mosdós
Teva Investigational Site 51136, Nyíregyháza
Teva Investigational Site 51139, Nyíregyháza
Teva Investigational Site 51163, Sopron
Teva Investigational Site 51137, Szeged
Teva Investigational Site 51164, Szigetvár
Teva Investigational Site 51138, Szombathely
Teva Investigational Site 53182, Bialystok
Teva Investigational Site 53183, Bialystok
Teva Investigational Site 53185, Bialystok
Teva Investigational Site 53191, Bialystok
Teva Investigational Site 53187, Bienkówka
Teva Investigational Site 53219, Bydgoszcz
Teva Investigational Site 53217, Dębica
Teva Investigational Site 53178, Krakow
Teva Investigational Site 53180, Krakow
Teva Investigational Site 53188, Krakow
Teva Investigational Site 53220, Lodz
Teva Investigational Site 53235, Lodz
Teva Investigational Site 53221, Lódz
Teva Investigational Site 53237, Lublin
Teva Investigational Site 53194, Poznan
Teva Investigational Site 53234, Poznan
Teva Investigational Site 53233, Strzelce Opolskie
Teva Investigational Site 53179, Tarnów
Teva Investigational Site 53218, Tarnów
Teva Investigational Site 53193, Warsaw
Teva Investigational Site 53181, Wroclaw
Teva Investigational Site 53189, Wroclaw
Teva Investigational Site 50236, Chelyabinsk
Teva Investigational Site 50227, Kazan'
Teva Investigational Site 50234, Moscow
Teva Investigational Site 50238, Moscow
Teva Investigational Site 50230, Novosibirsk
Teva Investigational Site 50224, Saint Petersburg
Teva Investigational Site 50231, Saint Petersburg
Teva Investigational Site 50233, Voronezh
Teva Investigational Site 50237, Yaroslavl
Teva Investigational Site 50226, Yekaterinburg
Teva Investigational Site 90002, Cape Town
Teva Investigational Site 90008, Cape Town
Teva Investigational Site 90005, Centurion
Teva Investigational Site 90001, Johannesburg
Teva Investigational Site 90003, Middelburg
Teva Investigational Site 90007, Pretoria
Teva Investigational Site 58125, Kharkiv
Teva Investigational Site 58126, Kharkiv
Teva Investigational Site 58127, Kyiv
Teva Investigational Site 58128, Kyiv
Teva Investigational Site 58129, Vinnytsia
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY